rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
9
|
pubmed:dateCreated |
2005-3-18
|
pubmed:abstractText |
Preliminary results using rituximab in extranodal marginal zone (MALT) non-Hodgkin's lymphoma (NHL) patients seem to indicate a relevant clinical activity. Aim of the present study is to investigate the efficacy of conventional weekly treatment using rituximab in gastric MALT NHL patients resistant/refractory or not suitable for eradication treatment, and to evaluate the relevance of the t(11; 18)(q21; q21) translocation and its possible role as a predictive criteria of response.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0732-183X
|
pubmed:author |
pubmed-author:BertoniFrancescoF,
pubmed-author:CalabreseLilianaL,
pubmed-author:ConconiAnnaritaA,
pubmed-author:CrostaCristianoC,
pubmed-author:FerreriAndrés J MAJ,
pubmed-author:LaszloDanieleD,
pubmed-author:MartinelliGiovanniG,
pubmed-author:PedrinisEnnioE,
pubmed-author:PonzoniMaurilioM,
pubmed-author:PruneriGiancarloG,
pubmed-author:ZuccaEmanueleE
|
pubmed:issnType |
Print
|
pubmed:day |
20
|
pubmed:volume |
23
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1979-83
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:15668468-Adult,
pubmed-meshheading:15668468-Aged,
pubmed-meshheading:15668468-Aged, 80 and over,
pubmed-meshheading:15668468-Antibodies, Monoclonal,
pubmed-meshheading:15668468-Antibodies, Monoclonal, Murine-Derived,
pubmed-meshheading:15668468-Antineoplastic Agents,
pubmed-meshheading:15668468-Female,
pubmed-meshheading:15668468-Helicobacter pylori,
pubmed-meshheading:15668468-Humans,
pubmed-meshheading:15668468-In Situ Hybridization, Fluorescence,
pubmed-meshheading:15668468-Lymphoma, B-Cell, Marginal Zone,
pubmed-meshheading:15668468-Lymphoma, Non-Hodgkin,
pubmed-meshheading:15668468-Male,
pubmed-meshheading:15668468-Middle Aged,
pubmed-meshheading:15668468-Stomach Neoplasms,
pubmed-meshheading:15668468-Translocation, Genetic
|
pubmed:year |
2005
|
pubmed:articleTitle |
Clinical activity of rituximab in gastric marginal zone non-Hodgkin's lymphoma resistant to or not eligible for anti-Helicobacter pylori therapy.
|
pubmed:affiliation |
European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy.
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|